SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-023298
Filing Date
2019-11-14
Accepted
2019-11-14 06:47:25
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_adialpharma.htm 10-Q 391099
2 CERTIFICATION f10q0919ex31-1_adial.htm EX-31.1 9881
3 CERTIFICATION f10q0919ex31-2_adial.htm EX-31.2 10064
4 CERTIFICATION f10q0919ex32-1_adial.htm EX-32.1 3807
5 CERTIFICATION f10q0919ex32-2_adial.htm EX-32.2 3789
6 GRAPHIC img_001.jpg GRAPHIC 112885
  Complete submission text file 0001213900-19-023298.txt   3417809

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adil-20190930.xml EX-101.INS 465288
8 XBRL SCHEMA FILE adil-20190930.xsd EX-101.SCH 56751
9 XBRL CALCULATION FILE adil-20190930_cal.xml EX-101.CAL 37752
10 XBRL DEFINITION FILE adil-20190930_def.xml EX-101.DEF 212885
11 XBRL LABEL FILE adil-20190930_lab.xml EX-101.LAB 374417
12 XBRL PRESENTATION FILE adil-20190930_pre.xml EX-101.PRE 293218
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 191216273
SIC: 2834 Pharmaceutical Preparations